Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.

The landscape of diagnosis and treatment of locally advanced and metastatic prostate cancer has seen an unprecedented evolution in recent years. Incorporation of results from pivotal studies is crucial for state-of-the-art counselling of patients and to inform treatment recommendations. However, in daily practice ambiguous situations may occur or various options may seem adequate. Furthermore, specific national regulations, e.g. availability of diagnostic tools and drug approvals, may influence treatment choices. This paper presents the voting results of a Swiss expert panel that convened in August 2024 and discussed selected questions addressed by an international panel of experts during the Advanced Prostate Cancer Conference held in Lugano in April 2024. The objective is to facilitate national harmonization of diagnosis and treatment of locally advanced and metastatic prostate cancer and thereby providing a basis for discussion with individuals with prostate cancer.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-05-01
DOI
https://doi.org/10.23785/praxis.2025.05.002
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.

Alexandros Papachristofilou, P. Niederberger, K. Reichel, Stefanie Fischer et al.
PubMed
Prostate Cancer Treatment and Research
article

Interdisciplinary Swiss Consensus Recommendations on Management of Advanced Prostate Cancer.

Alexandros Papachristofilou, P. Niederberger, K. Reichel, Stefanie Fischer, Vérane Achard, Ursula Vogl, Irene A. Burger, Aurelius Omlin, Anja Lorch, Lukas Prause, Arnoud J. Templeton, Mohamed Shelan, Richard Cathomas, Daniel Engeler, Rainer Grobholz, Daniel Eberli, Deborah Zihler, Daniel R. Zwahlen, Dilara Akhoundova, Petros Tsantoulis, Andreas Erdmann, Frank Stenner, Cyrill A. Rentsch
article en

Abstract

The landscape of diagnosis and treatment of locally advanced and metastatic prostate cancer has seen an unprecedented evolution in recent years. Incorporation of results from pivotal studies is crucial for state-of-the-art counselling of patients and to inform treatment recommendations. However, in daily practice ambiguous situations may occur or various options may seem adequate. Furthermore, specific national regulations, e.g. availability of diagnostic tools and drug approvals, may influence treatment choices. This paper presents the voting results of a Swiss expert panel that convened in August 2024 and discussed selected questions addressed by an international panel of experts during the Advanced Prostate Cancer Conference held in Lugano in April 2024. The objective is to facilitate national harmonization of diagnosis and treatment of locally advanced and metastatic prostate cancer and thereby providing a basis for discussion with individuals with prostate cancer.

PubMedVol. 114(5)
University of Geneva (CH), University of Bern (CH), University of Zurich (CH), Kantonsspital St. Gallen (CH), Triemli Hospital (CH), University Hospital of Bern (CH), University Hospital of Basel (CH), Kantonsspital Winterthur (CH), University Hospital of Zurich (CH), Institute of Oncology Research (CH), Luzerner Kantonsspital (CH), Institut Bergonié (FR), Kantonsspital Graubünden (CH), GastroZentrum Hirslanden Zürich (CH), Kantonsspital Aarau (CH)
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.